Stockreport

BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA [Yahoo! Finance]

BioCardia, Inc.  (BCDA) 
PDF BioCardia, Inc. FDA Substantive Review and Meeting Scheduled for Early Q2 SUNNYVALE, Calif., March 17, 2026 (GLOBE NEWSWIRE) BioCardia ® , Inc. [NASDAQ: BCDA] , a d [Read more]